GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Upper GI Tract/Sucrose vs Sucralose – Appetite stimulation
74

Sucrose vs Sucralose – Appetite stimulation

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated August 1, 2025

The study highlights key differences between sucrose (table sugar) and sucralose (a common artificial sweetener) in terms of their effects on appetite and brain activity:

Sucrose (Sugar):

  • Appetite Suppression: Sucrose consumption was associated with lower hunger levels.
  • Brain Activity: Sucrose reduced activity in the hypothalamus, the brain’s hunger regulation center. This suggests that sugar may signal satiety more effectively, potentially curbing appetite after consumption.

Sucralose (Artificial Sweetener):

  • Appetite Stimulation: Sucralose increased hypothalamic activity compared to sucrose, which is linked to heightened hunger signals. In some individuals, sucralose made them feel hungrier.
  • Brain Activity: Sucralose raised brain activity in the hypothalamus and increased communication between the hypothalamus and brain regions involved in motivation and decision-making. This suggests that sucralose may influence cravings and eating behavior.
  • Variable Effects: The impact of sucralose varied among individuals:
  • People with obesity or insulin resistance showed stronger brain responses to sucralose.
  • Women also exhibited heightened sensitivity to sucralose compared to men.

Comparison:

  • Sucrose appears to suppress appetite and reduce hunger-related brain activity, while sucralose may stimulate hunger-related brain activity and, in some cases, increase appetite.
  • Sucralose's effects on hunger and brain activity are more complex and may depend on individual factors such as metabolic health, gender, and body weight.

Implications:

The findings suggest that sucralose might not effectively mimic the appetite-regulating properties of sugar and could potentially lead to increased cravings or altered eating behavior in certain individuals. However, the study was short-term, and more research is needed to fully understand the long-term impacts of sucralose on appetite regulation and metabolic health.

Expert Recommendations:

Given the potential appetite-stimulating effects of sucralose and the health risks associated with excessive sugar consumption, experts currently recommend:

  • Limiting both sugar and artificial sweeteners.
  • Reducing overall sweetener use to support better metabolic health and avoid potential disruptions in hunger regulation.

Related Q&A

01

Long-Term PPI Use Does Not Increase Gastric Cancer Risk: BMJ | 2026

Introduction: Proton pump inhibitors (PPIs) are among the most widely prescribed medications worldwide. Concerns have persisted that long-term acid suppression, through hypochlorhydria and hypergastrinemia, might increase gastric cancer...

02

Liquid Nitrogen Spray Cryotherapy Offers Repeatable Palliation in Advanced Oesophagal Cancer: GIE | August 2026

Introduction: Dysphagia from advanced unresectable oesophagal cancer can severely impair nutrition and quality of life. Conventional palliation often relies on stenting or feeding-tube placement, both of which carry...

03

Primary Tumour Genomics May Predict Recurrence Patterns After Gastric Cancer Surgery: JAMA Surgery | August 2026

Introduction: Despite curative-intent resection, gastric cancer carries a substantial risk of recurrence, commonly through hematogenous, peritoneal, or lymphatic spread. Current postoperative surveillance is largely guided by clinicopathological factors....

04

Autoimmune Gastritis: Diagnosis and Management: Nature Reviews Gastroenterology & Hepatology | August 2026

Introduction: Autoimmune gastritis (AIG) is a chronic immune-mediated disorder targeting the gastric oxyntic mucosa, resulting in progressive atrophy and impaired absorption of vitamin B12, iron, and other micronutrients....

05

Nicotine E-Cigarettes for Smoking Cessation: JAMA | July 2026

Introduction: Cigarette smoking remains one of the leading causes of preventable death worldwide. This expert consensus statement from the Society for Research on Nicotine and Tobacco (SRNT) provides...

06

Dupilumab in Eosinophilic Gastritis: Nature Reviews Gastroenterology & Hepatology | July 2026

Introduction: Eosinophilic gastritis (EoG) is a rare chronic inflammatory disorder with limited effective treatment options and frequent dependence on corticosteroids. The phase II DEGAS trial evaluated dupilumab, an...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer